S. 527 Reported by committee Commerce

Prescription Pricing for the People Act of 2025

A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

  1. Introduced
  2. Committee
  3. Passed Senate
  4. Passed House
  5. To President
  6. Became law
Sponsor Sen. Grassley, Chuck [R-IA] Introduced February 11, 2025 Cosponsors 13 (6 D, 7 R) Latest action April 10, 2025

Summary

Prescription Pricing for the People Act of 2025

This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs.
The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs.
The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations.
Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.

Summary by the Congressional Research Service, Library of Congress.

Congress.gov

Actions

  1. Apr 10, 2025 Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
  2. Apr 10, 2025 Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
  3. Apr 3, 2025 Committee on the Judiciary. Ordered to be reported without amendment favorably.
  4. Feb 11, 2025 Read twice and referred to the Committee on the Judiciary.
  5. Feb 11, 2025 Introduced in Senate

Congressional and federal records come from official public sources: the House Clerk, the U.S. Senate, GovInfo and the Library of Congress (bill status), the Federal Register, and the congress-legislators project. They are copied on a schedule and may lag the official record by a few hours; the official sources govern. News and coverage counts are drawn from the 4Conservative index and reflect what the press published, not 4Conservative's views. Nothing here is an endorsement of any candidate, party or position. Terms of use.